Department of Molecular Oncology
BC Cancer, part of the Provincial Health Services Authority
  • Home
  • About
    • People
    • Location
    • Contact Us
  • Aparicio Lab
    • Personnel
    • Research
    • Datasets
  • Benard Lab
    • Personnel
    • Research
  • Huntsman Lab
    • Research
  • Lin Lab
    • Personnel
    • Research
  • Schrader Lab
    • Personnel
  • Shah Lab
    • Personnel
    • Research
  • Sorensen Lab
    • Personnel
    • Research
  • Platforms
    • Bimolecular fluorescence complementation (BiFC)
    • Breast Tumour Bank
    • Computational Biology
    • High-content Genetic Screens
    • Next Generation Sequencing
    • Tissue Microarrays
  • News
  • Careers
» Home » Pfizer Canada

Pfizer Canada

BC Cancer Agency and Pfizer Oncology scientists identify the P-cadherin protein as a prognostic biomarker in breast cancer

October 28, 2010

Scientists from the BC Cancer Agency and Pfizer Oncology have published the first results of their three-year research collaboration. The paper, published in the journal Modern Pathology, analyzed the expression of the P-cadherin protein in breast cancer. P-cadherin is involved in controlling the development and function of the normal mammary gland, but may also play […]

Posted in Aparicio Lab, News And Events, Papers | Tagged with Aparicio, BCCA, BCCRC, Modern Pathology, P-cadherin, Pfizer Canada, Research, Turashvili

Recent Posts

  • Graduate Student Position at the BC Cancer Research Centre, Vancouver, Canada
  • Post-doctoral Fellow – Aparicio Lab
  • Research Assistant / Tech 3 Position
  • Research Animal Technician 2 – Benard Lab

RSS Pubmed Feed – Molecular Oncology

  • Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial.
Tweets by @bccancer_molonc